Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine

Journal:

The New England Journal of Medicine

Published:

2025-11-20

DOI:

10.1056/nejmoa2416779

Affiliations:

10

Authors:

19

Go to article

Institutions	Authors	Share
Pfizer, United States of America (USA)	12.000000 12.000000	0.63
Pfizer Ltd., United Kingdom (UK)	2.000000	0.11
Entrust Clinical Research, United States of America (USA)	1.000000	0.05
East-West Medical Research Institute, United States of America (USA)	1.000000	0.05
Kaiser Permanente Washington Health Research Institute (KPWHRI), United States of America (USA)	1.000000	0.05
Palm Springs Community Health Center, United States of America (USA)	1.000000	0.05
Wilmington Health, United States of America (USA)	1.000000	0.05

Interested in Immunology?